0001209191-23-012672.txt : 20230224
0001209191-23-012672.hdr.sgml : 20230224
20230224160638
ACCESSION NUMBER: 0001209191-23-012672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230222
FILED AS OF DATE: 20230224
DATE AS OF CHANGE: 20230224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23667047
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2023-02-22
4
S
0
129
291.84
D
68576
D
Common Stock
2023-02-22
4
S
0
300
292.86
D
68276
D
Common Stock
2023-02-22
4
S
0
1378
294.29
D
66898
D
Common Stock
2023-02-22
4
S
0
394
295.38
D
66504
D
Common Stock
2023-02-22
4
S
0
200
296.31
D
66304
D
Common Stock
140
I
401(k)
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $291.84 (range $291.17 to $292.03).
Open market sales reported on this line occurred at a weighted average price of $292.86 (range $292.44 to $293.37).
Open market sales reported on this line occurred at a weighted average price of $294.29 (range $293.83 to $294.82).
Open market sales reported on this line occurred at a weighted average price of $295.38 (range $294.83 to $295.72).
Open market sales reported on this line occurred at a weighted average price of $296.31 (range $296.20 to $296.41).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-02-24